News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,022 Results
Type
Article (86016)
Company Profile (649)
Press Release (751357)
Section
Business (232197)
Career Advice (4124)
Deals (39704)
Drug Delivery (125)
Drug Development (90781)
Employer Resources (198)
FDA (17983)
Job Trends (17314)
News (395509)
Policy (39650)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2989)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (78)
Alliances (56633)
ALS (78)
Alzheimer's disease (1459)
Antibody-drug conjugate (ADC) (130)
Approvals (17978)
Artificial intelligence (218)
Autoimmune disease (23)
Automation (10)
Bankruptcy (401)
Best Places to Work (12514)
BIOSECURE Act (21)
Biosimilars (116)
Biotechnology (447)
Bladder cancer (60)
Brain cancer (26)
Breast cancer (216)
Cancer (1872)
Cardiovascular disease (137)
Career advice (3529)
Career pathing (33)
CAR-T (151)
Cell therapy (428)
Cervical cancer (17)
Clinical research (72716)
Collaboration (744)
Compensation (415)
Complete response letters (28)
COVID-19 (2830)
CRISPR (41)
C-suite (207)
Cystic fibrosis (99)
Data (1766)
Decentralized trials (2)
Denatured (43)
Depression (37)
Diabetes (183)
Diagnostics (6761)
Digital health (10)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (114)
Drug pricing (91)
Drug shortages (17)
Duchenne muscular dystrophy (79)
Earnings (95197)
Editorial (34)
Employer branding (25)
Employer resources (167)
Events (128136)
Executive appointments (576)
FDA (18899)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (621)
Gene editing (94)
Generative AI (22)
Gene therapy (303)
GLP-1 (726)
Government (5088)
Grass and pollen (4)
Guidances (35)
Healthcare (20748)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (119)
Indications (22)
Infectious disease (2942)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (42)
Intellectual property (83)
Interviews (812)
IPO (17691)
IRA (38)
Job creations (5183)
Job search strategy (2861)
Kidney cancer (10)
Labor market (37)
Layoffs (530)
Leadership (20)
Legal (10057)
Liver cancer (69)
Lung cancer (278)
Lymphoma (122)
Machine learning (3)
Management (65)
Manufacturing (272)
MASH (65)
Medical device (14318)
Medtech (14323)
Mergers & acquisitions (22265)
Metabolic disorders (576)
Multiple sclerosis (71)
NASH (22)
Neurodegenerative disease (95)
Neuropsychiatric disorders (23)
Neuroscience (1939)
NextGen: Class of 2025 (7666)
Non-profit (5054)
Northern California (2201)
Now hiring (38)
Obesity (306)
Opinion (268)
Ovarian cancer (68)
Pain (66)
Pancreatic cancer (59)
Parkinson's disease (132)
Partnered (18)
Patents (186)
Patient recruitment (87)
Peanut (48)
People (64795)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22458)
Phase II (31611)
Phase III (23779)
Pipeline (972)
Podcasts (123)
Policy (120)
Postmarket research (3543)
Preclinical (10082)
Press Release (72)
Prostate cancer (79)
Psychedelics (34)
Radiopharmaceuticals (250)
Rare diseases (355)
Real estate (7382)
Recruiting (75)
Regulatory (26390)
Reports (56)
Research institute (2646)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (4)
RSV (32)
Schizophrenia (68)
Series A (123)
Series B (70)
Service/supplier (26)
Sickle cell disease (45)
Southern California (1901)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (33)
Startups (4282)
State (2)
Stomach cancer (12)
Supply chain (47)
Tariffs (17)
The Weekly (78)
United States (19095)
Vaccines (721)
Venture capitalists (37)
Webinars (13)
Weight loss (223)
Women's health (35)
Worklife (19)
Date
Today (62)
Last 7 days (394)
Last 30 days (2187)
Last 365 days (30195)
2025 (7394)
2024 (34306)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (52)
Alaska (6)
Arizona (241)
Arkansas (8)
Asia (49861)
Australia (8796)
California (5020)
Canada (1549)
China (478)
Colorado (161)
Connecticut (206)
Delaware (118)
Europe (113923)
Florida (621)
Georgia (143)
Hawaii (1)
Idaho (64)
Illinois (431)
India (26)
Indiana (261)
Iowa (9)
Japan (136)
Kansas (109)
Kentucky (16)
Louisiana (9)
Maine (58)
Maryland (824)
Massachusetts (3978)
Michigan (180)
Minnesota (311)
Mississippi (1)
Missouri (54)
Montana (24)
Nebraska (26)
Nevada (51)
New Hampshire (50)
New Jersey (1468)
New Mexico (27)
New York (1428)
North Carolina (977)
North Dakota (7)
Northern California (2201)
Ohio (159)
Oklahoma (13)
Oregon (44)
Pennsylvania (1064)
Puerto Rico (10)
Rhode Island (21)
South America (1647)
South Carolina (4)
South Dakota (1)
Southern California (1901)
Tennessee (30)
Texas (665)
Utah (118)
Virginia (116)
Washington D.C. (38)
Washington State (500)
West Virginia (1)
Wisconsin (38)
838,022 Results for "epic bio pte ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Newly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics
March 6, 2025
·
5 min read
Government
Congress Re-Introduces EPIC Act to Remove IRA’s ‘Pill Penalty’
While many industry players and observers have high hopes for the EPIC Act, some say budgetary headwinds could make it difficult for the current administration to make meaningful repeals or amendments to the IRA.
February 26, 2025
·
2 min read
·
Tristan Manalac
Biotech Bay
Epic Bio to Present IND-Enabling Data Package for EPI-321 at FSHD International Research Congress
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, announced its participation in the upcoming FSHD International Research Congress being held June 13-14, 2024, in Denver, Colo.
June 7, 2024
·
2 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Canaccord Genuity Genetic Medicine for Generalists
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced that Amber Salzman, Ph.D., chief executive officer, participated in a fireside chat at the Canaccord Genuity - Genetic Medicine for Generalists Fireside Chat today.
April 10, 2024
·
1 min read
Biotech Bay
Epic Bio to Participate in a Fireside Chat at the Cantor Virtual Muscular Dystrophy Symposium
Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman, Ph.D., chief executive officer, will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium at 9:40 a.m. PT, Tuesday, April 2, 2024.
April 1, 2024
·
1 min read
Biotech Bay
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
Epic Bio, a leading epigenetic editing company that plans to dose its first patients later this year, today announced that Amber Salzman, Ph.D., chief executive officer, will present at the Charles River Cell & Gene Therapy Summit at 2:00 p.m. PT, Tuesday, March 19, 2024, in South San Francisco, Calif.
March 13, 2024
·
1 min read
Biotech Bay
Epic Bio Announces Robust Slate of Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Epic Bio, a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, today announced the acceptance of six abstracts, three oral presentations, and three poster presentations at the upcoming Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 7-11, 2024, in Baltimore, Maryland.
April 9, 2024
·
2 min read
Biotech Bay
Epic Bio to Present at the Upcoming CRISPR2.0 Conference
Epic Bio announced a presentation at the upcoming CRISPR2.0 conference being held November 28-30, 2023, at the Hilton Boston Back Bay, Boston Massachusetts.
November 21, 2023
·
1 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
Biotech Bay
Epic Bio to Participate in Upcoming November 2023 Investor Conference
Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins, announced that the management will participate in an upcoming investor conference.
November 7, 2023
·
1 min read
1 of 83,803
Next
